Antioxidants for female subfertility

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 7, 2017, Pages 1-154

  Showell, Marian G ^a   Mackenzie Proctor, Rebecca ^b   Jordan, Vanessa ^a   Hart, Roger J ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CALCIUM; CARNITINE; CHIRO INOSITOL; INOSITOL DERIVATIVE; MELATONIN; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; SELENIUM; UBIDECARENONE; UNCLASSIFIED DRUG; VITAMIN B COMPLEX; VITAMIN D;

ARTICLE; ENDOMETRIOSIS; FEMALE SUBFERTILITY; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; HYDROSALPINX; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MULTIPLE PREGNANCY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; ABORTION, SPONTANEOUS; FEMALE; INFERTILITY, FEMALE; LIVE BIRTH; META ANALYSIS; ORAL DRUG ADMINISTRATION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ABORTION, SPONTANEOUS; ADMINISTRATION, ORAL; ANTIOXIDANTS; FEMALE; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; OXIDATIVE STRESS; PENTOXIFYLLINE; PREGNANCY; PREGNANCY RATE; PREGNANCY, MULTIPLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85026450932     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007807.pub3     Document Type: Article

References (172)

1. Agrawal R, Burt E,Gallagher AM, Butler L, Venkatakrishnan R, Peitsidis P. Prospective randomized trial of multiple micronutrients in subfertile women undergoing ovulation induction: a pilot study. Reproductive Biomedicine Online 2012;24(1):54-60.
2. Alborzi S, Ghotbi S, Parsanezhad ME, Dehbashi S, Alborzi S, Alborzi M. Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study. Journal of Minimally Invasive Gynecology 2007;14(1):54-8.
3. Ghotbi S, Parsanezhad ME, Dehbashi S, Alborzi S, Alborzi M. Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: A prospective, doubleblind, randomized, placebo-controlled study. Journal of Minimally Invasive Gynecology 2007; Vol. 14, issue 1: 54-8.
4. Aleyasin A, Aghahosseini M, Mohseni M, Mahavi A. Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine 2009;7:175-9.
5. Badawy A, El Nashar AB, El Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertility and Sterility 2006;86(3):647-50.
6. Balasch J, Creus M, Fabregues F, Carmona F, Martinez-Roman S, Manau D, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis. Human Reproduction 1997;12(9):2046-50.
7. Batioglu AS, Sahin U, Gurlek B, Ozturk N, Unsal E. The efficacy of melatonin administration on oocyte quality. Gynecological Endocrinology 2012; Vol. 28, issue 2:91-3.
8. Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Adjuvant L-arginine treatment for invitro fertilization in poor responder patients. Human Reproduction 1999; Vol. 14, issue 7:1690-7.
9. Battaglia C, Regani G, Marsella T, Facchinetti F, Volpe A, Venturoli S. Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind randomized study. Human Reproduction 2002;17(3):659-65.
10. Bentov Y, HannamT, Jurisicova A, Esfandiari N, Casper RF. Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clinical Medicine Insights. Reproductive Health 2014;8:31-6.
11. Brusco GF, Mariani M. Inositol: Effects on oocyte quality in patients undergoing ICSI. An open study. European Review for Medical and Pharmacological Sciences 2013; Vol. 17, issue 22:3095-102.
12. Carlomagno G, Montanino Oliva M, Roseff SJ, Unfer V. Myo-inositol: Ovarian stimulation and IVF outcomes. Fertility and Sterility 2012; Vol. 98 Suppl 1, issue 3:S74-S75 Abstract no:O-251.
13. *Cheraghi E, Mehranjani MS, Shariatzadeh MA, Esfahani MHN, Ebrahimi Z. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperminjection: An alternative to metformin. Reproduction, Fertility, and Development 2016; Vol. 28, issue 6:723-31.
14. Cheraghi E, Shariatzadeh MA, Soleimani M, Nasr Esfahani MH, Ebrahimi Z. Association of follicular fluid endocrine changes with oocyte morphology and quality in PCOS patients undergoing metformin and N-acetylcysteine treatment. International Journal of Fertility and Sterility 2013;7 Suppl 1:44.
15. Cheraghi E, Soleimani Mehranjani M, Ali Shariatzadeh M, Nasr Esfahani M, Ebrahimi Z. Co-administration of metformin and N-Acetyl Cysteine fails to improve clinical manifestations in PCOS individual undergoing ICSI. International Journal of Fertility and Sterility 2014;8:119-28.
16. Cheraghi E, Soleimani Mehranjani M, Shariatzadeh SM, Nasr Esfahani MH, Ebrahimi Z. Expression changes of GDF-9 and BMP-15 in the oocytes of PCOS patients undergoing treatment with N-acetylcysteine. International Journal of Fertility and Sterility 2014;8 Suppl 1:201.
17. Choi S-Y, Kim CH, Ahn J-W, Kwon S-K, Lee K-H, Kang B-M. Effect of calcium and vitamin D supplementation on follicular fluid tumor necrosis-alpha and interleukin-6 and IVF/ICSI outcomes in infertile patients with polycystic ovary syndrome. Fertility and Sterility 2012; Vol. 98 Suppl 1, issue 3:S208-S209 Abstract no:P-326.
18. Cicek N, Eryilmaz OG, Sarikaya E, Gulerman C, Genc Y. Vitamin E: Effect on controlled ovarian stimulation of unexplained infertile women. Journal of Assisted Reproduction and Genetics 2012; Vol. 29, issue 4:325-8.
19. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. European Review for Medical & Pharmacological Sciences 2011;15(5):509-14.
20. Colazingari S, Treglia M, Najjar R, Bevilacqua A. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics 2013;288(6):1405-11.
21. Creus M, Fabregues F, Carmona F, Del Pino M, Manau D, Balasch J. Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial. Human Reproduction 2008;23:1910-6.
22. Daneshbodi H, Vaziri N, Nadjarzadeh A, Lotfi MH, Mozaffari-Khosravi H. Effect of omega-3 supplementation on gonadotropins and prolactin levels in women with polycystic ovary syndrome: A double blinded randomized controlled trial. Iranian Journal of Reproductive Medicine. Research and Clinical Center for Infertitlity, 2013; Vol. 11: 58-9.
23. Deeba F, Fatima P. Multiple micronutrients (MMN) in infertile women undergoing ovulation induction: A randomized control trial. Journal of Obstetrics and Gynaecology research. Blackwell Publishing, 2015; Vol. 41: 170.
24. El Refaeey A, Selem A, Badawy A. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. Reproductive Biomedicine Online 2014;29(1):119-24.
25. Eryilmaz OG, Devran A, Sarikaya E, Aksakal FN, Mollamahmutoglu L, Cicek N. Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems. Journal of Assisted Reproduction & Genetics 2011; Vol. 28, issue 9:815-20.
26. Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. European Review for Medical & Pharmacological Sciences 2003;7(6):151-9.
27. *Gerli S, Papaleo E, Ferrari A, Di Renzo G. Randomized, double blind placebo-controlled trial: effects of myoinositol on ovarian function and metabolic factors in women with PCOS. Eurpoean Review for Medical and Pharmacolgical Sciences 2007;11:347-54.
28. Griesinger G, Franke K, Kinast C, Kutzelnigg A, Riedinger S, Kulin S, et al. Ascorbic acid supplement during luteal phase in IVF. Journal of Assisted Reproduction and Genetics 2002;19(4):164-8.
29. Ismail AM, Hamed AH, Saso S, Thabet HH. Adding Lcarnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. European Journal of Obstetrics Gynecology and Reproductive Biology 2014;180:148-52.
30. Keikha F. Combination N-acetyl cysteine and clomiphene citrate in clomiphene citrate-resistant polycystic ovary syndrome. Iranian Journal of Reproductive Medicine. Research and Clinical Center for Infertitlity, 2010; Vol. 8: 12-3.
31. Kim C, Lee S, Koo Y, Lee H, Lee Y, Jeon I, et al. N-acetylcysteine treatment improves insulin sensitivity, ovarian response to gonadotrophin and IVF outcome in patients with polycystic ovary syndrome. ESHRE Conference Proceedings. 18 -21 June 2006; Vol. I:178.
32. Kim CH, Yoon JW, Ahn JW, Kang HJ, Lee JW, Kang BM. The effect of supplementation with omega-3-polyunsaturated fatty acids in intracytoplasmic sperm injection cycles for infertile patients with a history of unexplained total fertilization failure. Fertility and Sterility 2010;94(4):S242. Abstract no P-518.
33. Lesoine B, Regidor PA. Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality. International Journal of Endocrinology 2016; Vol. 2016 (no pagination), issue 4378507.
34. Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, et al. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reproductive Biology and Endocrinology 2012; Vol. 10:52. [DOI: 10.1186/ 1477-7827-10-52]
35. Maged AM, Elsawah H, Abdelhafez A, Bakry A, Mostafa WA. The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with polycystic ovary syndrome. Gynecological Endocrinology 2015; Vol. 31, issue 8:635-8.
36. Mier-Cabrera J, Geenera-Garcia M, De la Jara-Diaz, Perichart-Perera Otilla, Vadillo-Ortega F, Hernandez-Guerrero C. Effect of vitamins C and E supplementation on peripheral oxidative stress markers and pregnancy rate in women with endometriosis. International Journal of Gynecology and Obstetrics 2008;100:252-6.
37. Mohammadbeigi R, Afkhamzadeh A, Daneshpour NS. The effect of calcium-vitamin D in efficacy of induction ovulation in infertile women with polycystic ovary syndrome. Iranian Journal of Obstetrics, Gynecology and Infertility 2012;15:7-13.
38. Nasr A. Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study. Reproductive BioMedicine Online 2010;20(3):403-9.
39. *Ozkaya MO, NazIroglu M, Barak C, Berkkanoglu M. Effects of multivitamin/mineral supplementation on trace element levels in serum and follicular fluid of women undergoing in vitro fertilization (IVF). Biological Trace Element Research 2011; Vol. 139, issue 1:1-9.
40. Ozkaya MO, Nazrolu M. Multivitamin and mineral supplementation modulates oxidative stress and antioxidant vitamin levels in serum and follicular fluid of women undergoing in vitro fertilization. Fertility and Sterility 2010; 94(6):2465-6.
41. Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecological Endocrinology 2016; Vol. 32, issue 1:69-73.
42. Panti Abubakar A, Egondu Shehu C, Saidu Y, Nwobodo EI, Tunau Abubakar K, Jimoh A, et al. Oxidative stress and antioxidant supplementation in patients with polycystic ovarian syndrome (PCOS). International Journal of Gynecology and Obstetrics 2015; Vol. 131 Suppl 5:E505.
43. Papaleo E, Unfer V, Baillargeon J, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles: a prospective, controlled, randomized trial. Fertility and Sterility 2009;91 (5):1750-4.
44. Polak de Fried E, Bossi NM, Notrica JA, Vazquez Levin MH. Vitamin-d treatment does not improve pregnancy rates in patients undergoing art: a prospective, randomized, double-blind placebo-controlled trial. Fertility and Sterility 2013;100(Suppl):S493.
45. Rashidi B, Haghollahia F, ShariataM, Zayeriia F. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwanese Journal of Obstetrics and Gynecology 2009;48(2):142-7.
46. Razavi M, Jamilian M, Kashan ZF, Heidar Z, Mohseni M, Ghandi Y, et al. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Hormone and Metabolic Research 2015; Vol. 48, issue 3: 185-90.
47. Rezk A, Bedaiwy M, El Enany H. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrateresistant patients with polycystic ovary syndrome. Human Reproduction; Abstracts of the 20th Annual Meeting of the ESHRE, June 27-30. 2004 2004;19:i53.
48. *Rizk A, Bedaiwy M, Al-Inany H. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrateresistant patients with polycystic ovary syndrome. Fertility and Sterility 2005;83(2):367-70.
49. Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles: a prospective, clinical trial. European Review for Medical & Pharmacological Sciences 2010;14(6):555-61.
50. Rosalbino I, Raffone E. Does ovary need D-chiro-inositol?. Journal of Ovarian Research 2012; Vol. 5, issue 1:14.
51. Salehpour S, Tohidi M, Akhound M, Amirzargar N. N acetyl cysteine, a novel remedy for polycystic ovary syndrome. International Journal of Fertility and Sterility 2009;3(2):66-73.
52. Salehpour S, Akbari Sene A, Saharkhiz N, Sohrabi M, Moghimian F. N-acetyl-cysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. Iranian Journal of Reproductive Medicine 2012; Vol. 10 Suppl 1: 18 Abstract no: O-30.
53. Salehpour S, Akbari Sene A, Saharkhiz N, Sohrabi M, Moghimian F. N-acetyl-cysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. Iranian Journal of Reproductive Medicine. Research and Clinical Center for Infertitlity, 2012; Vol. 10:9.
54. *Salehpour S, Akbari Sene A, Saharkhiz N, Sohrabi MR, Moghimian F. N-acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. Journal of Obstetrics & Gynaecology Research 2012;38:1182-6.
55. Schachter M, Raziel A, Strassburger D, Rotem C, Ron-El R, Friedler S. Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome. Fertility & Sterility. 2007; Vol. 88, issue 1:227-30.
56. Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles: a prospective, controlled, randomized trial. European Review for Medical and Pharmacological Sciences 2011;15(4):452-7.
57. Valeri C, Sbracia G, Selman H, Antonini G, Pacchiarotti A. Beneficial effects of melatonin on oocytes and embryo quality in aged IVF patients. Human Reproduction 2015; 30:i48-9.
58. Westphal LM, Polan ML, Trant AS. Double-blind, placebocontrolled study of Fertilityblend: a nutritional supplement for improving fertility in women. Clinical and Experimental Obstetrics & Gynecology 2006;33(4):205-8.
59. Aboulfoutouh I, Youssef M, Khattab S. Can antioxidants supplementation improve ICSI/IVF outcomes in women undergoing IVF/ICSI treatment cycles? Randomised controlled study. Fertility and Sterility 2011;96 Suppl 3: S242-9.
60. *Youssef MA, Abdelmoty HI, Elashmwi HA, Abduljawad EM, Elghamary N, Magdy A, et al. Oral antioxidants supplementation for women with unexplained infertility undergoing ICSI/IVF: randomized controlled trial. Human Fertility 2015; Vol. 18, issue 1:38-42.
61. Aflatoonian A, Arabjahvani F, Eftekhar M, Sayadi M. Effect of vitamin D insufficiency treatment on fertility outcomes in frozen-thawed embryo transfer cycles: A randomized clinical trial. Iranian Journal of Reproductive Medicine 2014; 12(9):595-600.
62. Aksoy AN, Kadanali S. Evaluating the effects of vitamin E addition to clomiphene citrate on endometrial receptivity: a prospective controlled study. Turkiye Klinikleri Jinekoloji Obstetrik 2010;20(2):71-6.
63. Al-Omari W, Abdul-Qadder A, Sulaiman W, Taher M. Antioxidants improve metabolic and ovarian response in polycsytic ovary syndrome. ESHRE. 2003; Vol. xviii:84.
64. Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutrition Research 2012;32(3): 195-201.
65. Asadi M, Matin N, Frootan M, Mohamadpour J, Qorbani M, Tanha FD. Vitamin D improves endometrial thickness in PCOS women who need intrauterine insemination: A randomized double-blind placebo-controlled trial. Archives of Gynecology and Obstetrics 2014;289(4):865-870.
66. Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Apridonidze T, He N, Nestler JE. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism 2004; Vol. 89, issue 1:242-9.
67. Benelli E, Del Ghianda S, Di Cosmo C, Tonacchera M. A combined therapy with myo-inositol and d-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology 2016; Vol. 2016:3204083.
68. Bonakdaran S, Khorasani ZM, Davachi B, Shakeri MT. Comparison of calcitriol and metformin effects on clinical and metabolic consequences of polycystic ovary syndrome. Iranian Journal of Obstetrics, Gynecology and Infertility 2012; 14(8):16-24.
69. Cheang KI, Baillargeon J-P, Essah PA, Ostlund RE Jr, Apridonize T, Islam L, et al. Insulin-stimulated release of dchiro-inositol-containing inositol phosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental 2008; Vol. 57, issue 10:1390-7.
70. Ciotta L, Stracquadanio M, Pagano I, Formuso C, Di Leo S, Cianci A. D-chiro-inositol treatment in patients with polycystic ovary syndrome. Giornale Italiano di Ostetricia e Ginecologia 2012;34(1):145-8.
71. Costantino D, Minozzi G, Minozzi F, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. European Review for Medical and Pharmacological Sciences 2009;13(2):105-10.
72. Crha I, Hruba D, Ventruba P, Fiala J, Totusek J, Visnova H. Ascorbic acid and infertility treatment. Central European Journal of Public Health 2003;11(2):63-7.
73. Elgindy EA, El-Huseiny AM, Mostafa MI, Gaballah AM, Ahmed TA. N-acetyl cysteine: could be an effective adjuvant therapy in ICSI cycles. ASRM. September 2008; Vol. 90:suppl 1.
74. Elgindy EA, El-Huseiny AM, Mostafa MI, Gaballah AM, Ahmed TA. N-acetyl cysteine: could it be an effective adjuvant therapy in ICSI cycles? A preliminary study. Reproductive Biomedicine Online. 2010;20(6):789-96.
75. Elnashar A, Fahmy M, Mansour A, Ibrahim K. N-acetyl cysteine versus metformin in treatment of clomiphene citrate-resistant polycystic ovarysyndrome: a randomized study. 12th Annual Meeting of the Middle East Fertility Society. 2005; Vol. 10 Suppl 1.
76. Elnashar A, Fahmy M, Mansour A, Ibrahim K. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovarysyndrome: a prospective randomized controlled study. Fertility and Sterility 2007;88 (2):407-11.
77. Elnashar A. Fahmy M. Mansour A. Ibrahim K. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertility and Sterility 2007;88 (2):406-9.
78. Farzadi L, Salman Zadeh S. Metformin-therapy effects in 50 clomiphene citrate resistant PCOS patients. Journal of Medical Sciences 2006;6(5):765-71.
79. Firouzabadi RD, Aflatoonian A, Modarresi S, Sekhavat L, Mohammad Taheri S. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complementary Therapies in Clinical Practice 2012;18(2): 85-8.
80. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myoinositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecological Endocrinology 2008;24(3):139-44.
81. Hashim HA, Anwar K, El-Fatah RA. N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. Journal ofWomen's Health 2010;19(11):2043-8.
82. Hebisha SA, Abdelhaleem BA, Salaam HN. Follicular fluid homocysteine with acetyl cysteine supplemented ovarian stimulation: Correlation with oocyte yield and ICSI cycle outcome. Reproductive BioMedicine Online 2016; Vol. 32:S5.
83. *Hebisha SA, Mahmoud HM. Follicular fluid homocysteine levels with acetyl cysteine supplemented ovarian stimulation: correlation with oocyte yield and ICSI outcome. International Journal of Advanced Research 2016;4 (9):1906-9.
84. Hebisha SA, Omran MS, Sallam HN, Ahmed AI. Follicular fluid homocysteine levels with N-acetyl cysteine supplemented controlled ovarian hyperstimulation, correlation with oocyte yield and ICSI cycle outcome. Fertility and Sterility 2015; Vol. 104 Suppl, issue 3:e324.
85. Henmi H, Endo T, Kitajima Y, Manase K, Hata H, Kudo R. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertility & Sterility 2003;80(2):459-61.
86. Hernández-Yero A, Santana Pérez F, Ovies Carballo G, Cabrera-Rode E. Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemia. International Journal of Endocrinology 2012:382719.
87. Immediata V, Romualdi D, De Cicco S, Tagliaferri V, Di Florio C, Cirella E, et al. Metformin versus myoinositol: which one is better in obese PCOS patients -a crossover study on clinical, endocrine and metabolic effects. Human Reproduction 2014; Vol. 29 suppl 1:i334 Abstract no: P-522.
88. Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, et al. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice 2002;8(6):417-23.
89. Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A. The effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebocontrolled trial. Biological Trace Element Research: 2016; Vol. 172, issue 1:72-8.
90. Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z. Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biological Trace Element Research 2016; Vol. 170, issue 2: 271-8.
91. Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. Journal of Minimally Invasive Gynecology 2008;15(1):62-6.
92. Thiel JA, Kamencic H. Pentoxifylline (trental) after conservative surgery for endometriosis: a randomized control trial [abstract]. Journal of Minimally Invasive Gynecology 2006;(13 Suppl 5):S10.
93. Kilicdag EB, Bagis T, Tarim E, Aslan E, Erkanli S, Simsek E, et al. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Human Reproduction 2005; Vol. 20, issue 6:1521-8.
94. Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U. Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition. Minerva Ginecologica 2012;64(1):23-9.
95. Li Y, Ma H, Zhang Y, Kuang H, Ng EHY, Hou L, et al. Effect of berberine on insulin resistance in women with polycystic ovary syndrome: Study protocol for a randomized multicenter controlled trial. Trials 2013; Vol. 14, issue 1: 226.
96. Moosavifar N, Mohammadpour AH, Jallali M, Karimiz G, Saberi H. Evaluation of effect of silymarin on granulosa cell apoptosis and follicular development in patients undergoing in vitro fertilization. Eastern Mediterranean Health Journal 2010;16(6):642-5.
97. Nazzaro A, Salerno A, Marino S, Granato C, Pastore E. The addition of melatonin to myo-inositol plus folic acid improves oocyte quality and pregnancy outcome in IVF cycle: a prospective clinical trial. Human Reproduction 2011;26:i227-8.
98. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine 1999; Vol. 340, issue 17:1314-20.
99. Nestler J, Gunn R, Bates S, Gregory J, Jacobson W, Rogol A. D-chiro-inositol (INS-1) enhances ovulatory rate in hyperandrogenemic, oligomenorrheic women with the polycystic ovary syndrome. Fertility & Sterility 2001; Vol. 76, issue 3 Suppl 1:S110-1.
100. Nichols J. A randomised controlled trial to compare conception rates for preconceptional folic acid 400 mg daily versus Pregnacare Plus in assisted conception. World Health Organization International Clinical Trials Registry Platform 2010. ISRCTN23488518]
101. Nordio M, Proietti E. The combined therapy with myoinositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myoinositol supplementation alone. European Review for Medical & Pharmacological Sciences 2012;16(5):575-81.
102. Oner G, Muderris II. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 2011;159(1):127-31.
103. Pal L, Zhang H, Williams J, Santoro NF, Diamond MP, Schlaff WD, et al. Vitamin D status relates to reproductive outcome in women with polycystic ovary syndrome: Secondary analysis of a multicenter randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 2016; Vol. 101, issue 8:3027-35.
104. Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecological Endocrinology 2007;23(12):700-3.
105. Papaleo E, De Santis, Baillargeon JP, Zacchè M, Fusi FM, Brigante C, et al. Comparison of myo-inositol plus folic acid vs clomiphene citrate for first-line treatment in women with polycystic ovary syndrome. Human Reproduction ESHRE 24th Annual Meeting, Barcelona, 6-9 July 2008. 2008; Vol. 23 Suppl 1 Abstract No: O-251 Oral.
106. Pasha NG. Assessment of the effect of Ca-vitamin D and metformin on PCOS. WHO International Clinical Trials Registry Platform Search Portal. IRCT: IRCT201009131760N9]
107. Pizzo A, Lagana AS, Barbaro L. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecological Endocrinology 2014;30(3):205-8.
108. Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology 2010;26(4):275-80.
109. Ruder EH, Hartman TJ, Reindollar RH, Goldman MB. Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility. Fertility and Sterility. United States: Elsevier Inc. (360 Park Avenue South, New York NY 10010, United States), 2014; Vol. 101, issue 3:759-66.
110. Salem HT, Ismail A. L-carnitin as a treatment in clomiphene resistant PCO for improving quality of ovulation and pregnancy outcome; a novel treatment. Human Reproduction 2012; Vol. 27 Suppl 2:ii302-ii337: Abstract number: P-529.
111. Santanam N, Kavtaradze N, Dominguez C, Rock J, Partasarathy S, Murphy A. Antioxidant supplementation reduces total chemokines and inflammatory cytokines in women with endometriosis. Fertility & Sterility 2003; Vol. 80, issue Suppl 3:S32-3. Abstract no: O-85.
112. Taheri M, Modarres M, Abdollahi A. The effect of vitamin d supplementation on anti-mullerian hormone levels in reproductive-age women. Reproduction, Fertility and Development 2015;27:185-6.
113. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. Journal of Pineal Research 2008; 44(3):280-7.
114. Twigt JM, Hammiche F, Sinclair KD, Beckers NG, Visser JA, Lindemans J, et al. Preconception folic acid use modulates estradiol and follicular responses to ovarian stimulation. Journal of Clinical Endocrinology and Metabolism 2011;96(2):E322-9.
115. Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 2011;60(12):1711-8.
116. Yoon JW, Kim CH, Ahn JW, Kang HJ, Song BM. Effect of omega-3-polyunsaturated fatty acids and metformin on ovarian morphology and intraovarian blood flow in patients with polycystic ovary syndrome. Fertility & Sterility. 2010; Vol. 94/4 Abstract no. P-346:S194. ISSN: 0015-0282]
117. CTRI/2012/08/002943. Nutritional supplement for women with polycystic ovary syndrome or subfertility. ctri.nic.in/Clinicaltrials/pdf?generate.php? trialid=5002&EncHid=&modid=&compid=%27%27, %27%275002det%27%27 31st August 2012.
118. Fernando S, Osianlis T, Vollenhoven B, Wallace E, Rombauts L. A pilot double-blind randomised placebocontrolled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol. BMJ open 2014; Vol. 4, issue 8:e005986.
119. Mahdian A. Impacts of calcium-vitamin D supplementary on ovulation in polycystic ovary syndrome. IRCT.
120. NCT01019785. Vitamin D during in vitro fertilisation (IVF) -a prospective randomised trial (delivery). clinicaltrials.gov/show/NCT01019785 23 November 2009. ClinicalTrials.gov: NCT01019785]
121. NCT01267604. Improving oocyte retrieval using a combined therapy of recombinant follicle stimulating hormone (rFSH) and inositol and melatonin. clinicaltrials.gov/ct2/show/NCT01267604 23rd December 2010. NCT01267604]
122. NCT01782911. Effect of Resveratol on metabolic parameters and oocyte quality in PCOS patients (RESIVF). clinicaltrials.gov/ct2/show/NCT01782911 28th January 2013.
123. NCT02058212. Use of antioxidant in endometriotic women to improve intracytoplasmic sperm injection (ICSI). clinicaltrials.gov/ct2/show/NCT02058212 5th February 2014.
124. NCT03023514. Lipoic acid supplementation in IVF. clinicaltrials.gov/ct2/show/NCT03023514 13th January 2017.
125. 2016 Global Supplement Report. www.marketresearch.com/Nutrition-Business-Journalv2520/ Global-Supplement-10063772/.
126. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reproductive Biology and Endocrinology 2012;10:49.
127. Badawy A, State O, Abdelgawad S. N-acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstetricia et Gynecologica Scandinavica 2007;86(2):218-22.
128. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD004183.pub3]
129. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD007176.pub2]
130. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Human Reproduction (Oxford, England) 2007;22(6): 1506-12.
131. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility. Fertility and Sterility 2008;89:668-76.
132. Clarke J, Van Rumste M, Farquhar C, Johnson N, Mol B, Herbison P. Measuring outcomes in fertility trials -can we rely on clinical pregnancy rates?. Fertility and Sterility 2010; 94(5):1647-51.
133. Dias S, McNamee R, Vail A. Evidence for improving quality of reporting randomized controlled trials in subfertility. Human Reproduction 2006;21(10):2617-27.
134. Drugs.com. Pentoxifylline official FDA information, side effects and uses. www.drugs.com/pro/pentoxifylline.html (Accessed 26.06.13).
135. Ebisch I, Thomas C, PetersW, Braat D, Steegers-Theunissen R. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Human Reproduction Update 2007;13(2):163-74.
136. Evers J. Female subfertility. Lancet 2002;360(9327):151-9.
137. GRADEpro Guideline Development Tool [Software]. McMaster University (developed by Evidence Prime, Inc.). 2015.
138. Grajecki D, Zyriax B-C, Buhling KJ. The effect of micronutrient supplements on female fertility: a systematic review. Archives of Gynecology and Obstetrics 2012;285(5): 1463-71.
139. Gupta S, Agarwal A, Banerjee J, Alvarez JG. The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstetrical and Gynecological Survey 2007;62(5):335-47.
140. Haggarty P, McCallum H, McBain H, Andrews K, Duthie S, McNeill G, et al. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet 2006;367(9521):1513-9.
141. Hart R. Unexplained infertility, endometriosis, and fibroids. BMJ 2003;327(7417):721-4.
142. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.handbook.cochrane.org.
143. Irani M, Merhi Z. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertility and Sterility 2014;102(2):460-8.e3.
144. Ko EY, Sabanegh ES Jr. The role of over-the-counter supplements for the treatment of male infertility--fact or fiction?. Journal of Andrology 2012;33(3):292-308.
145. Ledee-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Human Reproduction 2002;17:1249-53.
146. Levin I, Almog B, Shwartz T, Gold V, Ben-Yosef D, Shaubi M, et al. Effects of laser polar-body biopsy on embryo quality. Fertility and Sterility 2012;97(5):1085-8.
147. Lu D, Song H, Li Y, Clarke J, Shi G. Pentoxifylline for endometriosis. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD007677.pub3]
148. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Medicine 2012;9(12):e1001356.
149. Mintel. Vitamin and supplements market in good health: 46% of all Brits are daily users. www.mintel.com/presscentre/ social-and-lifestyle/vitamin-and-supplementsmarket-in-good-health-46-of-all-brits-are-daily-users 21st September 2016.
150. Nestler JE. Myo-inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions. Journal of BasicClinical Physiological Pharmacology 1998;9(2-4): 197-204.
151. NHS. Supplements: who needs them? NHS choices. www.nhs.uk/news/2011/05May/Documents/ BtH?supplements.pdf (Accessed 25th June 2017).
152. O'Reilly E, Sevigny M, Sabarre K-A, Phillips KP. Perspectives of complementary and alternative medicine (CAM) practitioners in the support and treatment of infertility. BMC Complementary and Alternative Medicine 2014;14:394.
153. Oliva A, Dotta A, Multigner L. Pentoxifylline and antioxidants improve sperm quality in male patients with varicocoele. Fertility & Sterility 2009;91 Suppl 4:1536-9.
154. Pacis MM, Fortin CN, Zarek SM, Mumford SL, Segars JH. Vitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic review. Journal of Assisted Reproduction and Genetics 2015; 32(3):323-35.
155. Reportlinker. Vitamin and supplement industry: market research reports, statistics and analysis, 2010. www.reportlinker.com/ci02037/Vitamin-and-Supplement.html.
156. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
157. Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress and antioxidants: exposure and impact on female fertility. Human Reproduction Update 2008;14(4): 345-57.
158. Sekhon L, Gupta S, Kim Y, Agarwal A. Female infertility and antioxidants. Current Women's Health Reviews 2010;6: 84-95.
159. Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/ 14651858.CD007411.pub2]
160. Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD007411.pub3]
161. Showell MG, Mackenzie-Proctor R, Jordan V, Hodgson R, Brown J, Farquhar C. Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/ 14651858.CD012378; CD012378]
162. Stankiewicz M, Smith C, Alino H, Norman R. The use of complementary medicine and therapies by patients attending a reproductive medicine unit in South Australia: a prospective survey. Australian and New Zealand Journal of Obstetrics and Gynaecology 2007;47(2):145-9. [DOI: 10.1111/j.1479-828X.2007.00702.x]
163. Takasaki A, Tamura H, Taniguchi K, Asada H, Taketani T, Matsuoka A, et al. Luteal blood flow and luteal function. Journal of Ovarian Research 2009;2:1.
164. Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical Endocrinology 2012;77(3):343-50.
165. Tremellen K. Oxidative stress and male infertility -a clinical perspective. Human Reproduction Update 2008;14(3): 243-58.
166. Unfer V, Nestler JE, Kamenov ZA, Prapas N, Facchinetti F. Effects of inositol(s) in women with PCOS: a systematic review of randomized controlled trials. International Journal of Endocrinology 2016;2016:1849162.
167. Vircheva S, Alexandrova A, Georgieva A, Mateeva P, Zamfirova R, Kubera M. In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation. Cell Biochemistry & Function 2010;28(8):668-72.
168. Wathes DC, Abayasekara DR, Aitken RJ. Polyunsaturated fatty acids in male and female reproduction. Biology of Reproduction 2007;77(2):190-201.
169. Zegers-Hochschild F, Adamson GD, DeMouzon J, Ishihara O, Mansour R, Nygren K, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertility and Sterility 2009;92(5):1520-4.
170. Zhao W, Mosley BS, Cleves MA, Melnyk S, James SJ, Hobbs CA. Neural tube defects and maternal bio markers of folate, homocysteine, and glutathione metabolism. Birth Defects Research Part A: Clinical and Molecular Teratology 2006;76(4):230-6. [DOI: 10.1002/bdra.20240]
171. Clarke J, Showell MG, Hart RJ, Agarwal A, Gupta S. Antioxidants for female subfertility. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/ 14651858.CD007807]
172. Showell MG, Brown J, Clarke J, Hart RJ. Antioxidants for female subfertility. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD007807.pub2]